抗炎症薬市場：薬剤タイプ別、用途別、投与経路別、流通チャネル別、地域別

世界の抗炎症薬市場は、2025年には1,155億5,000万米ドルと推定され、2032年には2,100億2,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR8.9％で成長すると予測されています。

図.抗炎症薬市場シェア（%）、2025年地域別

抗炎症薬は、体内の炎症を抑える薬です。関節痛や関節炎など、炎症や痛みを伴う疾患の治療によく使用されます。抗炎症薬の主なクラス別には、非ステロイド性抗炎症薬（NSAIDs）、コルチコステロイド／ステロイド、生物学的製剤、インターロイキンブロッカーなどがあります。イブプロフェンやナプロキセンを含む非ステロイド性抗炎症薬は、その有効性とOTCでの入手可能性から、最も一般的に使用されている抗炎症薬のひとつです。老年人口の増加、関節炎やその他の炎症性疾患の有病率の上昇、炎症性疾患に対する意識の高まり、新製品の発売などが、近い将来の抗炎症薬市場の成長を促進する可能性があります。

市場力学：

世界の抗炎症薬市場の成長は、老年人口の増加、関節炎やその他の炎症性疾患の有病率の上昇、炎症性疾患に対する意識の高まり、新製品の承認や発売などの要因によって牽引されます。推計によると、世界中で3億人以上の人々が関節リウマチに苦しんでいます。人口の高齢化により、関節炎や炎症性疾患の患者数は大幅に増加すると予測されています。このため、これらの疾患の治療用として抗炎症薬の需要が高まる可能性があります。しかし、薬の副作用、ブロックバスター薬の特許切れ、栄養補助食品のような代替品の開発といった要因が、市場の成長を妨げる可能性があります。新興国は、国際的なプレーヤーがプレゼンスを拡大するための有利な機会を提供する可能性があります。革新的な製剤技術の研究開発や、有効性と安全性を向上させた生物製剤の開発も、新たな機会を提供する可能性があります。

本調査の主な特徴

• 本レポートでは、世界の抗炎症薬市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の抗炎症薬市場における主要企業プロファイルを掲載しています。
• このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• 世界の抗炎症薬市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の抗炎症薬市場の分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の抗炎症薬市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の抗炎症薬市場、薬剤タイプ別、2020年-2032年（10億米ドル）

• 非ステロイド性抗炎症薬（NSAlD）
• 免疫選択的抗炎症誘導体（ImSAlD）
• 抗炎症生物学的製剤
• コルチコステロイド

第6章 世界の抗炎症薬市場、用途別、2020年-2032年、（10億米ドル）

• 関節炎
• 慢性閉塞性肺疾患（COPD）
• 多発性硬化症
• 炎症性腸疾患（IBD）
• 痛風
• その他

第7章 世界の抗炎症薬市場、投与経路別、2020年-2032年、（10億米ドル）

• 経口
• 塗布
• 注射
• 吸入

第8章 世界の抗炎症薬市場、流通チャネル別、2020年-2032年、（10億米ドル）

• 病院薬局
• 小売薬局
• オンライン薬局

第9章 世界の抗炎症薬市場、地域別、2020年-2032年、（10億米ドル）

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋

Global Anti-Inflammatory Drugs Market is estimated to be valued at USD 115.55 Bn in 2025 and is expected to reach USD 210.02 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032.

Figure. Anti-Inflammatory Drugs Market Share (%), By Region 2025

Anti-inflammatory drugs are medications that reduce inflammation in the body. These are commonly used to treat joint pain, arthritis, and other conditions associated with inflammation and pain. Some of the major classes of anti-inflammatory drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids/steroids, biologics, and interleukin blockers. NSAIDs including ibuprofen and naproxen are among the most commonly used anti-inflammatory medications due to their effectiveness and OTC availability. Growing geriatric population, rising prevalence of arthritis and other inflammatory diseases, increasing awareness about inflammatory conditions, and new product launches can drive the anti-inflammatory drugs market growth in the near future.

Market Dynamics:

Global anti-inflammatory drugs market growth is driven by factors such as growing geriatric population, rising prevalence of arthritis and other inflammatory diseases, increasing awareness about inflammatory conditions, new product approvals and launches. As per estimates, over 300 million people suffer from rheumatoid arthritis worldwide. The number of arthritis and inflammatory disease cases is projected to increase significantly due to aging population. This can boost demand for anti-inflammatory drugs for treatment of these diseases. However, factors such as adverse side effects of medications, patent expiries of blockbuster drugs, and development of alternatives like nutraceuticals can hamper the market growth. Emerging economies can offer lucrative opportunities for international players to expand their presence. Ongoing research on innovative formulation technologies and development of biologics with improved efficacy and safety profile can also offer new opportunities.

Key features of the study:

• This report provides in-depth analysis of the global anti-inflammatory drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global anti-inflammatory drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Abbott, Zydus Cadila, Sanofi, Merck, Roche, and Bayer
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global anti-inflammatory drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-inflammatory drugs market

Detailed Segmentation-

• By Drug Type
  • Nonsteroidal Anti-inflammatory Drugs (NSAlDs)
  • Immune Selective Anti-inflammatory Derivatives (ImSAlDs)
  • Anti-inflammatory Biologics
  • Corticosteroids
• By Application
  • Arthritis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Multiple Sclerosis
  • Inflammatory Bowel Disease (IBD)
  • Gout
  • Others
• By Route of Administration
  • Oral
  • Topical
  • Injection
  • Inhalation
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Pfizer, Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Eli Lilly and Company
  • Sanofi
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZenica PLC
  • Roche Holding AG
  • Bristol Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Gilead Sciences, Inc.
  • Horizon Therapeutics plc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Type
  • Market Snapshot, By Application
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Anti-inflammatory Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Anti-inflammatory Drugs Market, By Drug Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Nonsteroidal Anti-inflammatory Drugs (NSAlDs)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immune Selective Anti-inflammatory Derivatives (ImSAlDs)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anti-inflammatory Biologics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Corticosteroids
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Anti-inflammatory Drugs Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Obstructive Pulmonary Disease (COPD)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multiple Sclerosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammatory Bowel Disease (IBD)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gout
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Topical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inhalation
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Anti-inflammatory Drugs Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

• Company Profiles
  • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Eli Lilly and Company
  • Sanofi
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Roche Holding AG
  • Bristol Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Gilead Sciences, Inc.
  • Horizon Therapeutics plc

11. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact